ITGA4+ITGB7
Related Services:
Loading...
| Catalog | Product name | Similar to | Antibody | Linker | Payload | Data sheet | Inquiry |
| ADC-W-2384 | Anti-ITGA4+ITGB7 (Abrilumab)-SMCC-DM1 ADC | Human Anti-ITGA4+ITGB7 IgG2-kappa antibody, Abrilumab | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
|
Inquiry | |
| ADC-W-2385 | Anti-ITGA4+ITGB7 (Abrilumab)-SPDB-DM4 ADC | Human Anti-ITGA4+ITGB7 IgG2-kappa antibody, Abrilumab | SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) | DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine) |
|
Inquiry | |
| ADC-W-2386 | Anti-ITGA4+ITGB7 (Abrilumab)-MC-MMAF ADC | Human Anti-ITGA4+ITGB7 IgG2-kappa antibody, Abrilumab | MC (maleimidocaproyl) | MMAF |
|
Inquiry | |
| ADC-W-2387 | Anti-ITGA4+ITGB7 (Abrilumab)-MC-Vc-PAB-MMAE ADC | Human Anti-ITGA4+ITGB7 IgG2-kappa antibody, Abrilumab | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
|
Inquiry | |
| ADC-W-2388 | Anti-ITGA4+ITGB7 (Abrilumab)-MC-Vc-PAB-SN38 ADC | Human Anti-ITGA4+ITGB7 IgG2-kappa antibody, Abrilumab | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | SN-38 (7-ethyl-10-hydroxycamptothecin) |
|
Inquiry | |
| ADC-W-2389 | Anti-ITGA4+ITGB7 (Abrilumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC | Human Anti-ITGA4+ITGB7 IgG2-kappa antibody, Abrilumab | MC-Vc-PAB-DMEA-(PEG2) | duocarmycin SA |
|
Inquiry | |
| ADC-W-2492 | Anti-ITGA4+ITGB7 (Vedolizumab)-SMCC-DM1 ADC | Humanized Anti-ITGA4+ITGB7 IgG1-kappa antibody, Vedolizumab | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
|
Inquiry | |
| ADC-W-2493 | Anti-ITGA4+ITGB7 (Vedolizumab)-SPDB-DM4 ADC | Humanized Anti-ITGA4+ITGB7 IgG1-kappa antibody, Vedolizumab | SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) | DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine) |
|
Inquiry | |
| ADC-W-2494 | Anti-ITGA4+ITGB7 (Vedolizumab)-MC-MMAF ADC | Humanized Anti-ITGA4+ITGB7 IgG1-kappa antibody, Vedolizumab | MC (maleimidocaproyl) | MMAF |
|
Inquiry | |
| ADC-W-2495 | Anti-ITGA4+ITGB7 (Vedolizumab)-MC-Vc-PAB-MMAE ADC | Humanized Anti-ITGA4+ITGB7 IgG1-kappa antibody, Vedolizumab | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
|
Inquiry | |
| ADC-W-2496 | Anti-ITGA4+ITGB7 (Vedolizumab)-MC-Vc-PAB-SN38 ADC | Humanized Anti-ITGA4+ITGB7 IgG1-kappa antibody, Vedolizumab | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | SN-38 (7-ethyl-10-hydroxycamptothecin) |
|
Inquiry | |
| ADC-W-2497 | Anti-ITGA4+ITGB7 (Vedolizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC | Humanized Anti-ITGA4+ITGB7 IgG1-kappa antibody, Vedolizumab | MC-Vc-PAB-DMEA-(PEG2) | duocarmycin SA |
|
Inquiry | |
| ADC-W-2498 | Anti-ITGA4+ITGB7 (Crenezumab)-SMCC-DM1 ADC | Humanized Anti-ITGA4+ITGB7 IgG1-kappa antibody, Vedolizumab | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
|
Inquiry | |
| ADC-W-2499 | Anti-ITGA4+ITGB7 (Crenezumab)-SPDB-DM4 ADC | Humanized Anti-ITGA4+ITGB7 IgG1-kappa antibody, Vedolizumab | SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) | DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine) |
|
Inquiry | |
| ADC-W-2500 | Anti-ITGA4+ITGB7 (Crenezumab)-MC-MMAF ADC | Humanized Anti-ITGA4+ITGB7 IgG1-kappa antibody, Vedolizumab | MC (maleimidocaproyl) | MMAF |
|
Inquiry | |
| ADC-W-2501 | Anti-ITGA4+ITGB7 (Crenezumab)-MC-Vc-PAB-MMAE ADC | Humanized Anti-ITGA4+ITGB7 IgG1-kappa antibody, Vedolizumab | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
|
Inquiry | |
| ADC-W-2502 | Anti-ITGA4+ITGB7 (Crenezumab)-MC-Vc-PAB-SN38 ADC | Humanized Anti-ITGA4+ITGB7 IgG1-kappa antibody, Vedolizumab | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | SN-38 (7-ethyl-10-hydroxycamptothecin) |
|
Inquiry | |
| ADC-W-2503 | Anti-ITGA4+ITGB7 (Crenezumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC | Humanized Anti-ITGA4+ITGB7 IgG1-kappa antibody, Vedolizumab | MC-Vc-PAB-DMEA-(PEG2) | duocarmycin SA |
|
Inquiry |
If you can’t find your product on this list? Please directly send email to info@creative-biolabs.com
For Research Use Only. NOT FOR CLINICAL USE.
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
